TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

SAN FRANCISCO—New research implicates erectile dysfunction (ED) as an independent risk factor for high-risk coronary artery calcification.

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD), according to the results of a worldwide study of 1,519 men with ED and CVD.

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD), according to the results of a worldwide study of 1,519 men with ED and CVD.

For men who have had external beam radiotherapy (EBRT) for prostate cancer, the greatest decline in sexual function is in the first 24 months post-treatment, with no significant changes thereafter, according to a report in the International Journal of Radiation Oncology, Biology, Physics (2010;76:31-35).

Older men with restless leg syndrome (RLS) are more likely to have erectile dysfunction (ED) than men without RLS—and dopamine may be the common denominator, according to a study.

Black men and Asian men are less likely to have severe erectile dysfunction (ED) than white men, according to a study of 78,445 men aged 45 to 69 years who were not diagnosed with prostate cancer.

LYON, FRANCE—Israeli researchers have reported promising preliminary results using low-intensity shock wave therapy to treat vasculogenic erectile dysfunction (ED).

Pentoxifylline sustained-release (PTX-SR) is moderately effective reducing penile curvature and plaque volume in men suffering from early Peyronie's disease, researchers concluded.

PHILADELPHIA—Erectile dysfunction (ED) is more common in patients with rheumatic disease—especially rheumatoid arthritis (RA)—than in the general population, according to new findings by an Irish research team.